pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy
Piotr Białas(Poznan University of Medical Sciences), Anders Bjartell(Malmö University)
Cited by 1
Related Papers
The STAT3 inhibitor galiellalactone inhibits the generation of MDSC‐like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
|The Prostate|2019|70
Cystatin C Is Downregulated in Prostate Cancer and Modulates Invasion of Prostate Cancer Cells via MAPK/Erk and Androgen Receptor Pathways
|PLoS ONE|2009|65
Cystatin C Is Highly Expressed in the Human Male Reproductive System
|Journal of Andrology|2004|37
Faculty Opinions recommendation of Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation.
|Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature|2008|0